Autologous Transobturator Fascia Lata Sling in Treatment of Female Stress Urinary Incontinence

Launched by AL-AZHAR UNIVERSITY · Dec 3, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a surgical treatment called the autologous transobturator fascia lata sling to help women who experience stress urinary incontinence. Stress urinary incontinence is a condition where women leak urine when they cough, laugh, or exercise. The goal of this trial is to see how effective this surgery is for women who have this condition, especially those who have not found relief from other treatments or prefer not to try them.

To be eligible for this study, participants need to be women experiencing genuine stress urinary incontinence or mixed incontinence where stress is the main issue. However, women with certain conditions, like severe urinary tract infections, previous surgeries for incontinence, or those who are currently pregnant, cannot participate. If you join the trial, you can expect to have the surgery performed at Al-Azhar University hospitals, and researchers will monitor your progress to evaluate how well the treatment works. It's important to know that this trial is currently recruiting participants, so there is an opportunity to help advance treatment options for this common issue.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women with genuine stress urinary incontinence.
• • Mixed urinary incontinence with predominant stress element.
• • Refractory cases to conservative therapy or patients who are not willing to consider (further) conservative treatment.
• Exclusion Criteria:
• • Mixed incontinence with predominant Urge urinary incontinence.
• • Associated local abnormalities that may affect surgery outcomes (e.g. complete procidentia).
• • Recent or active urinary tract infection.
• • Recent pelvic surgery.
• • Neurogenic lower urinary tract dysfunction.
• • Previous surgery for stress urinary incontinence.
• • Pregnancy
• • Less than 12 months post-partum.
• • Other gynaecologic pathologies affecting bladder functions ( eg, large fibroids, ovarian cysts)
• • Genito-urinary malignancy.
• • Current chemo or radiation therapy.